Literature DB >> 18793150

Innate link between NF-kappaB activity and ubiquitin-like modifiers.

Valérie Lang1, Manuel S Rodríguez.   

Abstract

Among the several signalling pathways regulated by ubiquitin and ubiquitin-like proteins, the one activating NF-kappaB (nuclear factor kappaB) is certainly one of the best characterized. The regulation of the activity of this transcription factor by members of the ubiquitin family occurs at various levels, imposing overlapping controls of security of intriguing complexity. The formation of active macromolecular complexes such as the IKK [IkappaB (inhibitory kappaB) kinase] complex is tightly regulated by these post-translational modifications probably due to the fact that many signals converge on this signal's roundabout. An additional, very important level of NF-kappaB control occurs through the partial or total proteolysis of precursor and inhibitor molecules exerted by the ubiquitin-proteasome pathway. Regulation at this level implicates various conjugating and de-conjugating activities for ubiquitin, SUMO (small ubiquitin-related modifier) and NEDD8. Here, we summarize some of these events and underline the importance of the interconnecting ubiquitin and ubiquitin-like conjugating pathways that determine the status of the activity of this critical transcription factor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18793150     DOI: 10.1042/BST0360853

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  8 in total

1.  Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities.

Authors:  Roland Hjerpe; Fabienne Aillet; Fernando Lopitz-Otsoa; Valerie Lang; Patrick England; Manuel S Rodriguez
Journal:  EMBO Rep       Date:  2009-10-02       Impact factor: 8.807

2.  Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9.

Authors:  Gretchen L Bentz; Christopher B Whitehurst; Joseph S Pagano
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

3.  LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.

Authors:  Gretchen L Bentz; Charles Randall Moss; Christopher B Whitehurst; Cary A Moody; Joseph S Pagano
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

4.  Role of monoubiquitylation on the control of IκBα degradation and NF-κB activity.

Authors:  Elisa Da Silva-Ferrada; Mónica Torres-Ramos; Fabienne Aillet; Michela Campagna; Carlos Matute; Carmen Rivas; Manuel S Rodríguez; Valérie Lang
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

5.  HOPS/Tmub1 involvement in the NF-kB-mediated inflammatory response through the modulation of TRAF6.

Authors:  Marina Maria Bellet; Stefania Pieroni; Marilena Castelli; Danilo Piobbico; Francesca Fallarino; Luigina Romani; Maria Agnese Della-Fazia; Giuseppe Servillo
Journal:  Cell Death Dis       Date:  2020-10-15       Impact factor: 8.469

6.  Heterologous SUMO-2/3-ubiquitin chains optimize IκBα degradation and NF-κB activity.

Authors:  Fabienne Aillet; Fernando Lopitz-Otsoa; Isabel Egaña; Roland Hjerpe; Paul Fraser; Ron T Hay; Manuel S Rodriguez; Valérie Lang
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

7.  α-catenin SUMOylation increases IκBα stability and inhibits breast cancer progression.

Authors:  Huan Chen; Zhaowei Xu; Xiahui Li; Yangyang Yang; Bowen Li; Yanan Li; Kangkai Xia; Jian Wang; Shujing Li; Miao Wang; Huijian Wu
Journal:  Oncogenesis       Date:  2018-03-13       Impact factor: 7.485

8.  Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway.

Authors:  Chao Yu; Shiyu Chen; Yuntao Guo; Chengyi Sun
Journal:  Theranostics       Date:  2018-05-11       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.